Cannabinoids, medical cannabis, and colorectal cancer immunotherapy
M Zaiachuk, N Pryimak, O Kovalchuk… - Frontiers in …, 2021 - frontiersin.org
Colorectal cancer is a major public health problem. Unfortunately, currently, no effective
curative option exists for this type of malignancy. The most promising cancer treatment …
curative option exists for this type of malignancy. The most promising cancer treatment …
Photodynamic therapy synergizes with PD-L1 checkpoint blockade for immunotherapy of CRC by multifunctional nanoparticles
Z Yuan, G Fan, H Wu, C Liu, Y Zhan, Y Qiu, C Shou… - Molecular Therapy, 2021 - cell.com
Checkpoint inhibitors, such as anti-PD-1/PD-L1 antibodies, have been shown to be
extraordinarily effective, but their durable response rate remains low, especially in colorectal …
extraordinarily effective, but their durable response rate remains low, especially in colorectal …
PD-1/PD-L1 immune checkpoint blockade-based combinational treatment: Immunotherapeutic amplification strategies against colorectal cancer
Y Chen, C Liu, S Zhu, X Liang, Q Zhang, X Luo… - International …, 2021 - Elsevier
Colorectal cancer (CRC) is one of the most common malignant tumours of the digestive
system, and most patients are already in an advanced stage at the time of diagnosis …
system, and most patients are already in an advanced stage at the time of diagnosis …
[HTML][HTML] INHBA is a novel mediator regulating cellular senescence and immune evasion in colorectal cancer
S Chen, Y Gong, Y Shen, Y Liu, Y Fu, Y Dai… - Journal of …, 2021 - ncbi.nlm.nih.gov
Colorectal cancer (CRC) is one of the most mortal cancers in the world. Multiple factors and
bio-processes are associated with in tumorigenesis and metastasis of CRC, including …
bio-processes are associated with in tumorigenesis and metastasis of CRC, including …
[HTML][HTML] A randomized phase III trial of personalized peptide vaccination for castration‑resistant prostate cancer progressing after docetaxel
M Noguchi, K Fujimoto, G Arai… - Oncology …, 2021 - spandidos-publications.com
First‑line chemotherapy for men with metastatic castration‑resistant prostate cancer
(mCRPC) has been employed to improve overall survival (OS) and progression‑free survival …
(mCRPC) has been employed to improve overall survival (OS) and progression‑free survival …
Single-cell analysis reveals characterization of infiltrating T cells in moderately differentiated colorectal cancer
X Yang, Q Qi, Y Pan, Q Zhou, Y Wu, J Zhuang… - Frontiers in …, 2021 - frontiersin.org
Objective This study aimed to characterize the tumor-infiltrating T cells in moderately
differentiated colorectal cancer. Methods Using single-cell RNA sequencing data of isolated …
differentiated colorectal cancer. Methods Using single-cell RNA sequencing data of isolated …
Immunotherapy for older patients with melanoma: From darkness to light?
D Iacono, MG Vitale, D Basile… - Pigment Cell & …, 2021 - Wiley Online Library
Approximately 40% of malignant melanomas are diagnosed in patients older than 65 years.
Elderly patients with melanoma present clinicopathological features related to a more …
Elderly patients with melanoma present clinicopathological features related to a more …
Immunomodulatory nanomedicine for colorectal cancer treatment: a landscape to be explored?
Colorectal cancer (CRC) is one of the deadliest cancers in the world mainly due to
metastasis events. Despite improvements, the available treatment modalities for metastatic …
metastasis events. Despite improvements, the available treatment modalities for metastatic …
[HTML][HTML] Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer
T Guo, Z Wang, Y Liu - Journal of Gastrointestinal Oncology, 2021 - ncbi.nlm.nih.gov
Background Gastrointestinal malignant cancers affect many sites in the intestinal tract,
including the colon. In this study, we purposed to improve prognostic predictions for colon …
including the colon. In this study, we purposed to improve prognostic predictions for colon …
Identification and Verification of a 17 Immune‐Related Gene Pair Prognostic Signature for Colon Cancer
Q Zhang, Z Feng, Y Zhang, S Shi… - BioMed Research …, 2021 - Wiley Online Library
Background. Colon cancer (CC) is a malignant tumor with a high incidence and poor
prognosis. Accumulating evidence shows that the immune signature plays an important role …
prognosis. Accumulating evidence shows that the immune signature plays an important role …